NCT06709040 2025-02-05
A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
Novo Nordisk A/S
Enrolling by invitation
Novo Nordisk A/S
Novo Nordisk A/S